Skip to main content

Teicoplanin Pharmacokinetics in Patients with Chronic Renal Failure

Clinical Pharmacokinetics volume 12, pages 292–301 (1987)Cite this article

Summary

The pharmacokinetic profile of teicoplanin, a new glycopeptide antibiotic active against Gram-positive aerobic and anaerobic bacteria, was studied in 5 healthy male volunteers and 29 adult patients with various degrees of renal impairment, given a single 3 mg/kg intravenous dose. Teicoplanin was assayed in plasma and urine specimens by a microbiological method.

Pharmacokinetic parameters for teicoplanin were estimated both by a 3-compartment open pharmacokinetic model and by non-compartmental analysis. Elimination half-life increased with the decrease in creatinine clearance and mean values ranged from 41 hours in volunteers to 163 hours in anuric patients. Renal failure did not affect either the volume of distribution of the central compartment (mean approximately 0.09 L/kg) or the steady-state volume of distribution (mean approximately 0.9 L/kg). Both total and renal clearance decreased with severity of disease, particularly the latter, while non-renal clearance was unaffected by renal failure. Average values were from 19 to 6 ml/min for total clearance and from 12 to 0.4 ml/min for renal clearance. There was a linear correlation between the total clearance of teicoplanin and creatinine clearance, as well as between renal clearance and creatinine clearance. The total urinary excretion of active teicoplanin averaged 65% of the administered dose in normal subjects, but was significantly reduced in the presence of renal insufficiency.

Guidelines for administration of teicoplanin in patients with renal failure are given.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

49,54 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  • Albin HC, Demotes-Mainard FM, Bouchet JL, Vincon GA, Martin-Dupont C. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis. Clinical Pharmacology and Therapeutics 38: 285–289, 1985

    PubMed  Article  CAS  Google Scholar 

  • Bardone MR, Paternoster M, Coronelli C. Teichomycins, new antibiotics from actinoplanes teichomyceticus nov. sp. 11: extraction and chemical characterization. Journal of Antibiotics 31: 170–177, 1978

    PubMed  Article  CAS  Google Scholar 

  • Benet LZ, Galeazzi RL. Noncompartmental determination of the steady-state volume of distribution. Journal of Pharmaceutical Sciences 68: 1071–1074, 1979

    PubMed  Article  CAS  Google Scholar 

  • Berti M, Pallanza R, Goldstein BP, Arioli V. Teichomycin A2, a new antibiotic from Actinoplanes: activity in vitro and in vivo. In Periti et al. (Eds) Current chemotherapy and immunotherapy, Vol. 1, Proceedings of the 12th International Congress of Chemotherapy, Florence, 19–24 July 1981, pp. 342–343, American Society of Microbiology, Washington, 1982

    Google Scholar 

  • Borghi A, Coronelli C, Faniuolo L, Allievi G, Pallanza R, Gallo GG. Teichomycins, new antibiotics from actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin). Journal of Antibiotics 37: 615–620, 1984

    PubMed  Article  CAS  Google Scholar 

  • Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Tobramycin kinetics during continuous ambulatory peritoneal dialysis. Clinical Pharmacology and Therapeutics 34: 110–116, 1983a

    PubMed  Article  CAS  Google Scholar 

  • Bunke CM, Aronoff GR, Brier ME, Sloan RS, Luft FC. Vancomycin kinetics during continuous ambulatory peritoneal dialysis. Clinical Pharmacology and Therapeutics 34: 631–637, 1983b

    PubMed  Article  CAS  Google Scholar 

  • Cynamon MH, Granato PA. Comparison of the in vitro activities of teichomycin A2 and vancomycin against staphylococci and enterococci. Antimicrobial Agents and Chemotherapy 21: 504–505, 1982

    PubMed  Article  CAS  Google Scholar 

  • Dettli L. Drug dosage in renal disease. In Gibaldi et al. (Eds) Handbook of clinical pharmacokinetics, pp. 261–279, ADIS Press, New York, 1983

    Google Scholar 

  • Dettli L. The kidney in pre-clinical and clinical pharmacokinetics. Japanese Journal Clinical Pharmacology and Therapeutics 15: 241–254, 1984

    Article  Google Scholar 

  • Farber BB. Vancomycin: Renewed interest in an old drug. European Journal of Clinical Microbiology 3: 1–3, 1984

    PubMed  Article  CAS  Google Scholar 

  • Galanakis N, Giamarellou H, Avlami A, Kanellakopoulou K, Dendrinos X, et al. Clinical; microbiological and kinetic evaluation of teicoplanin, a new antistaphylococcal antibiotic. 4th Mediterranean Congress of Chemotherapy, Rhodos, 19–25 October, 1984. Abstract no. 191, 1984

  • Gibaldi M, Perrier D. Pharmacokinetics, 2nd ed., Marcel Dekker, New York, 1982

    Google Scholar 

  • Gibson TP. Influence of renal disease on pharmacokinetics. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, pp. 32–56, Applied Therapeutics, San Francisco, 1980

    Google Scholar 

  • Merdjan H, Baumelou A, Diquet B, Chick O, Singlas E. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of hemodialysis and peritoneal dialysis. British Journal of Clinical Pharmacology 19: 211–217, 1985

    PubMed  Article  CAS  Google Scholar 

  • Pallanza R, Berti M, Goldstein BP, Mapelli E, Randisi E, et al. Teichomycin: in vitro and in vivo evaluation in comparison with other antibiotics. Journal of Antimicrobial Chemotherapy 11: 419–425, 1983

    PubMed  Article  CAS  Google Scholar 

  • Parenti F, Beretta G, Berti M, Arioli V. Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. I. Description of the producer strain, fermentation studies and biological properties. Journal of Antibiotics (Tokyo) 31: 276–283, 1978

    Article  CAS  Google Scholar 

  • Rocchetti M, Recchia M. SPBS: Statistical programs for biological sciences: Minicomputer software for applying routine biostatistical methods. Computers Programs Biomedicine 14: 7–20, 1982

    Article  CAS  Google Scholar 

  • Sacchi Landriani G, Guardabasso V, Rocchetti M. NL-FIT: a microcomputer program for non-linear fitting. Computer Programs Biomedicine 16: 35–42, 1983

    Article  Google Scholar 

  • Salahudeen AK, Wilkinson R, McAinsh J, Bateman DN. Atenolol pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. British Journal Clinical Pharmacology 18: 457–460, 1984

    Article  CAS  Google Scholar 

  • Somai P, Shapiro RS, Stockard H, Higgins JT. Unidirectional absorption of gentamicin from the peritoneum during continous ambulatory peritoneal dialysis. Clinical Pharmacology and Therapeutics 32: 113–121, 1982

    Article  Google Scholar 

  • Traina GL, Bonati M. Pharmacokinetics of teichoplanin in man after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 12: 119–128, 1984

    PubMed  CAS  Google Scholar 

  • Traina GL, Gentile MG, Fellin G, Rosina R, Cavenaghi L, et al. Teicoplanin pharmacokinetics in patients on continuous ambulatory peritoneal dialysis. European Journal of Clinical Pharmacology 31: 501–504, 1986

    PubMed  Article  CAS  Google Scholar 

  • Verbist L, Hendrickx B. Comparative activity of teichomycin and 11 other antibiotics against gram-positive cocci. 5th International Symposium on Future Trends in Chemotherapy, Pisa, May 1982, pp. 88, 1982

  • Williams AH, Grüneberg RN. Teicoplanin. Journal of Antimicrobial Chemotherapy 14: 441–448, 1984

    PubMed  Article  CAS  Google Scholar 

Download references

Author information

Affiliations

  1. Laboratory of Clinical Pharmacology, Istituto di Ricerche Farmacologiche ‘Mario Negro’, via Eritrea 62, 20157, Milano, Italy

    M. Bonati, G. L. Traina, G. Villa, A. Salvadeo, M. G. Gentile, G. Fellin, R. Rosina, L. Cavenaghi & G. Buniva

  2. Nephrology Department, Fondazione Clinica del Lavoro, Pavia, Italy

    M. Bonati, G. L. Traina, G. Villa, A. Salvadeo, M. G. Gentile, G. Fellin, R. Rosina, L. Cavenaghi & G. Buniva

  3. Nephrology Department, ‘S. Carlo’ Hospital, Milano, Italy

    M. Bonati, G. L. Traina, G. Villa, A. Salvadeo, M. G. Gentile, G. Fellin, R. Rosina, L. Cavenaghi & G. Buniva

  4. Lepetit Research Center, Milano, Italy

    M. Bonati, G. L. Traina, G. Villa, A. Salvadeo, M. G. Gentile, G. Fellin, R. Rosina, L. Cavenaghi & G. Buniva

Authors
  1. M. Bonati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. L. Traina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Villa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Salvadeo
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. G. Gentile
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Fellin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. R. Rosina
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. L. Cavenaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. G. Buniva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Bonati, M., Traina, G.L., Villa, G. et al. Teicoplanin Pharmacokinetics in Patients with Chronic Renal Failure. Clin-Pharmacokinet 12, 292–301 (1987). https://doi.org/10.2165/00003088-198712040-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198712040-00003

Keywords

  • Peritoneal Dialysis
  • Creatinine Clearance
  • Nephritis
  • Renal Clearance
  • Teicoplanin